Clincosm LogoSign in Get a demo

relapsed or refractory multiple myeloma

Showing 26 - 45 of 45
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (Immediate Release (IR) Formulation, Gastro-Retentive (GR)

Active, not recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Immediate Release (IR) Formulation
  • +3 more
  • West Hollywood, California
  • +21 more
Dec 21, 2021

Relapsed or Refractory Multiple Myeloma Trial in Tianjin, Hangzhou (Y150)

Recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Tianjin, Tianjin, China
  • +1 more
Aug 11, 2021

Relapsed or Refractory Multiple Myeloma Trial in Hangzhou (anti-BCMA CAR-T, Cyclophosphamid, Fludarabine)

Recruiting
  • Relapsed or Refractory Multiple Myeloma
  • anti-BCMA CAR-T
  • +2 more
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Apr 4, 2021

Relapsed or Refractory Multiple Myeloma Trial (Vorinostat, Bortezomib, Dexamethasone)

Completed
Has Results
  • Relapsed or Refractory Multiple Myeloma
  • (no location specified)
Mar 5, 2021

Relapsed or Refractory Multiple Myeloma Trial in United States (Dexamethasone, Carfilzomib)

Terminated
Has Results
  • Relapsed or Refractory Multiple Myeloma
  • Palm Springs, California
  • +30 more
Dec 14, 2020

Relapsed or Refractory Multiple Myeloma, Hematological Malignancy Trial in Maroochydore, Tugun, Frankston (SG301)

Not yet recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Hematological Malignancy
  • Maroochydore, Queensland, Australia
  • +2 more
Dec 21, 2020

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (TKI258)

Completed
  • Relapsed or Refractory Multiple Myeloma
  • Mobile, Alabama
  • +29 more
Dec 11, 2020

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (AUY922, Bortezomib, Dexamethasone)

Completed
  • Relapsed or Refractory Multiple Myeloma
  • Scottsdale, Arizona
  • +8 more
Dec 11, 2020

Relapsed or Refractory Multiple Myeloma Trial (Vorinostat, Lenalidomide, Dexamethasone)

Completed
Has Results
  • Relapsed or Refractory Multiple Myeloma
  • (no location specified)
Oct 27, 2020

Relapsed or Refractory Multiple Myeloma Trial in Shijiazhuang (BCMA CAR-T, Fludarabine, Cyclophosphamide)

Recruiting
  • Relapsed or Refractory Multiple Myeloma
  • BCMA CAR-T
  • +2 more
  • Shijiazhuang, Hebei, China
    the Second Hospital of HeBei Medical University (HBMU)
Nov 11, 2020

Relapsed or Refractory Multiple Myeloma Trial in Nanchang (Autologous BCMA CAR-T cells and CD19 CAR-T cells)

Unknown status
  • Relapsed or Refractory Multiple Myeloma
  • Autologous BCMA CAR-T cells and CD19 CAR-T cells
  • Nanchang, Jiangxi, China
    The First Affiliated Hospital of Nangchang University
Dec 10, 2019

Relapsed or Refractory Multiple Myeloma Trial in Nanjing (C-CAR088)

Unknown status
  • Relapsed or Refractory Multiple Myeloma
  • C-CAR088
  • Nanjing, Jiangsu, China
    the First Affiliated Hospital of Nanjing Medical University
Jul 1, 2019

Relapsed or Refractory Multiple Myeloma Trial in Sanhe (C-CAR088)

Unknown status
  • Relapsed or Refractory Multiple Myeloma
  • C-CAR088
  • Sanhe, Hebei, China
    Hebei Yanda Ludaopei Hospital
May 13, 2019

Relapsed or Refractory Multiple Myeloma Trial in New York (Lenalidomide, nab-paclitaxel)

Terminated
Has Results
  • Relapsed or Refractory Multiple Myeloma
  • New York, New York
    NYU School of Medicine
Sep 13, 2018

Relapsed or Refractory Multiple Myeloma Trial in United States (ALT-803)

Unknown status
  • Relapsed or Refractory Multiple Myeloma
  • ALT-803
  • Minneapolis, Minnesota
  • +3 more
Jan 19, 2018

Relapsed or Refractory Multiple Myeloma Trial in Tuebingen (Imnovid (pomalidomide), Dexamethasone, Endoxan (Cyclophosphamide))

Completed
  • Relapsed or Refractory Multiple Myeloma
  • Imnovid (pomalidomide)
  • +2 more
  • Tuebingen, Germany
    University Hospital
Oct 27, 2017

Relapsed or Refractory Multiple Myeloma Trial in United States (Cabozantinib (XL184))

Completed
Has Results
  • Relapsed or Refractory Multiple Myeloma
  • Cabozantinib (XL184)
  • Basking Ridge, New Jersey
  • +4 more
Aug 1, 2017

Relapsed or Refractory Multiple Myeloma Trial in Iowa City (ALT-801)

Terminated
  • Relapsed or Refractory Multiple Myeloma
  • ALT-801
  • Iowa City, Iowa
    University of Iowa Hospitals
Oct 26, 2016

Relapsed Or Refractory Multiple Myeloma Trial in St. Louis (thymoglobulin)

Completed
  • Relapsed Or Refractory Multiple Myeloma
  • St. Louis, Missouri
    Washington Unvierstiy in St. Louis
Apr 22, 2013

Relapsed or Refractory Multiple Myeloma Trial in Germany (Lenalidomide, dexamethasone)

Completed
Has Results
  • Relapsed or Refractory Multiple Myeloma
  • Berlin, Germany
  • +47 more
Sep 26, 2011